TLDR Juventus Fan Token (JUV) dropped more than 13% after Tether’s €1.1 billion takeover bid was rejected. Juventus Football Club shares jumped over 14% followingTLDR Juventus Fan Token (JUV) dropped more than 13% after Tether’s €1.1 billion takeover bid was rejected. Juventus Football Club shares jumped over 14% following

JUV Token Falls 13% After Juventus Rejects €1.1B Tether Takeover

TLDR

  • Juventus Fan Token (JUV) dropped more than 13% after Tether’s €1.1 billion takeover bid was rejected.
  • Juventus Football Club shares jumped over 14% following Exor’s decision to decline the offer.
  • Tether offered €2.66 per share in an all-cash deal, valuing Juventus at a 21% premium.
  • Exor controls 65.4% of Juventus and stated it has no intention of selling shares.
  • Tether holds an 11.53% stake in Juventus, while JUV trades below $0.74 after the decline.

Juventus Fan Token (JUV) dropped over 13% following the rejection of a €1.1 billion takeover bid by Tether. At the same time, Juventus Football Club’s shares surged 14% after Exor declined the offer. Tether’s proposal aimed to acquire a controlling stake at a 21% premium in an all-cash deal.

Tether’s Bid Rejected by Juventus Owner Exor

As it was reported in our recent news, Tether submitted a €1.1 billion all-cash bid on Friday to acquire Juventus Football Club from majority owner Exor. The proposal offered €2.66 per share, reflecting a 21% premium on Juventus’ last closing price. Exor owns 65.4% of the club and rejected the offer.

Exor released a statement on Saturday, confirming it would not sell any Juventus shares to Tether or any third party. Exor is controlled by the Agnelli family and also holds stakes in Stellantis and Ferrari. The company said it had “no intention of selling any of its shares in Juventus.”

Tether currently holds an 11.53% stake in Juventus and aims to expand its ownership through this acquisition attempt. The proposal, revealed in a letter sent to Exor, underlined Tether’s growing interest in professional sports. Tether operates USDT, the largest stablecoin by market capitalization.

JUV Token Falls While Club Shares Rise

According to a CoinDesk report, the JUV token climbed above $0.85 late Sunday before retreating to under $0.74 by early Monday. This marked a drop of more than 13% within hours following the bid rejection. The token had reached its highest value since early November. In contrast, Juventus shares rallied by over 14% on Monday to reach €2.50 during the trading session.

Market reaction to the takeover news pushed the stock higher after Tether’s proposal surfaced. Investors responded quickly once Exor’s rejection was confirmed. The fan token’s decline showed a contrasting reaction compared to equity markets. Fan tokens often respond differently to news affecting club ownership or business operations. JUV remains a blockchain-based asset for fan engagement, separate from the club’s official equity.

Crypto exchanges have spent $568 million on sports sponsorships for the 2024–2025 season, reports SportQuake. Soccer accounts for nearly 60% of all new sponsorship deals this season. Tether’s move reflected broader efforts by crypto firms to engage in sports ownership or partnerships. As of now, no revised offer or future intention has been disclosed by Tether. Juventus and Exor have made no further public comments. JUV continues trading below $0.74 while Juventus shares maintain gains.

The post JUV Token Falls 13% After Juventus Rejects €1.1B Tether Takeover appeared first on Blockonomi.

Market Opportunity
Juventus Logo
Juventus Price(JUV)
$0.7844
$0.7844$0.7844
+4.32%
USD
Juventus (JUV) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Over $145M Evaporates In Brutal Long Squeeze

Over $145M Evaporates In Brutal Long Squeeze

The post Over $145M Evaporates In Brutal Long Squeeze appeared on BitcoinEthereumNews.com. Crypto Futures Liquidations: Over $145M Evaporates In Brutal Long Squeeze
Share
BitcoinEthereumNews2026/01/16 11:35
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Edges higher ahead of BoC-Fed policy outcome

Edges higher ahead of BoC-Fed policy outcome

The post Edges higher ahead of BoC-Fed policy outcome appeared on BitcoinEthereumNews.com. USD/CAD gains marginally to near 1.3760 ahead of monetary policy announcements by the Fed and the BoC. Both the Fed and the BoC are expected to lower interest rates. USD/CAD forms a Head and Shoulder chart pattern. The USD/CAD pair ticks up to near 1.3760 during the late European session on Wednesday. The Loonie pair gains marginally ahead of monetary policy outcomes by the Bank of Canada (BoC) and the Federal Reserve (Fed) during New York trading hours. Both the BoC and the Fed are expected to cut interest rates amid mounting labor market conditions in their respective economies. Inflationary pressures in the Canadian economy have cooled down, emerging as another reason behind the BoC’s dovish expectations. However, the Fed is expected to start the monetary-easing campaign despite the United States (US) inflation remaining higher. Investors will closely monitor press conferences from both Fed Chair Jerome Powell and BoC Governor Tiff Macklem to get cues about whether there will be more interest rate cuts in the remainder of the year. According to analysts from Barclays, the Fed’s latest median projections for interest rates are likely to call for three interest rate cuts by 2025. Ahead of the Fed’s monetary policy, the US Dollar Index (DXY), which tracks the Greenback’s value against six major currencies, holds onto Tuesday’s losses near 96.60. USD/CAD forms a Head and Shoulder chart pattern, which indicates a bearish reversal. The neckline of the above-mentioned chart pattern is plotted near 1.3715. The near-term trend of the pair remains bearish as it stays below the 20-day Exponential Moving Average (EMA), which trades around 1.3800. The 14-day Relative Strength Index (RSI) slides to near 40.00. A fresh bearish momentum would emerge if the RSI falls below that level. Going forward, the asset could slide towards the round level of…
Share
BitcoinEthereumNews2025/09/18 01:23